Takafumi Nakamura
Yonago, 6838503, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Cell-cell fusion and immunostimulatory cytokines significantly impact oncolytic vaccinia virus immunotherapeutic potential.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 20, 2025
An artificial intelligence-assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions.
Journal: Molecular and clinical oncology
Published: August 25, 2021
Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
Journal: Cells
Published: February 15, 2021
Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression.
Journal: Molecular therapy oncolytics
Published: December 21, 2020
IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: September 18, 2020
Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2020
Long noncoding RNA UCA1 enhances sensitivity to oncolytic vaccinia virus by sponging miR-18a/miR-182 and modulating the Cdc42/filopodia axis in colorectal cancer.
Journal: Biochemical and biophysical research communications
Published: June 14, 2019
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.
Journal: Science translational medicine
Published: April 24, 2019
lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer.
Journal: Molecular therapy oncolytics
Published: January 26, 2019
Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function.
Journal: Molecular therapy oncolytics
Published: December 01, 2018
Last Updated: 09/26/2026